News | January 04, 2023
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Both manufacturing facilities are based out of Benguluru, India
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
Evidence also shows better immune response to virus among users of spray
Subscribe To Our Newsletter & Stay Updated
